Literature DB >> 14757863

Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure.

E Matichard, P Verpillat, R Meziani, B Gérard, V Descamps, E Legroux, M Burnouf, G Bertrand, F Bouscarat, A Archimbaud, C Picard, L Ollivaud, N Basset-Seguin, D Kerob, G Lanternier, C Lebbe, B Crickx, B Grandchamp, N Soufir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14757863      PMCID： PMC1735671          DOI： 10.1136/jmg.2003.011536

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  26 in total

1.  MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study.

Authors:  Anne Kricker; Bruce K Armstrong; Chris Goumas; Peter Kanetsky; Richard P Gallagher; Colin B Begg; Robert C Millikan; Terence Dwyer; Stefano Rosso; Loraine D Marrett; Nancy E Thomas; Marianne Berwick
Journal:  Cancer Causes Control       Date:  2010-08-19       Impact factor: 2.506

2.  CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.

Authors:  Georgia Koulermou; Christos Shammas; Andreas Vassiliou; Tassos C Kyriakides; Constantina Costi; Vassos Neocleous; Leonidas A Phylactou; Maria Pantelidou
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

Review 3.  Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis.

Authors:  Meg R Gerstenblith; Jianxin Shi; Maria Teresa Landi
Journal:  Pigment Cell Melanoma Res       Date:  2010-07-16       Impact factor: 4.693

4.  Cutaneous pharmacologic cAMP induction induces melanization of the skin and improves recovery from ultraviolet injury in melanocortin 1 receptor-intact or heterozygous skin.

Authors:  Robert-Marlo Bautista; Katharine Marie Carter; Stuart Gordon Jarrett; Dana Napier; Kazumasa Wakamatsu; Shosuke Ito; John August D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2019-08-24       Impact factor: 4.693

5.  Update on the Epidemiology of Melanoma.

Authors:  Steven T Chen; Alan C Geller; Hensin Tsao
Journal:  Curr Dermatol Rep       Date:  2013-03-01

6.  Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Authors:  F Demenais; H Mohamdi; V Chaudru; A M Goldstein; J A Newton Bishop; D T Bishop; P A Kanetsky; N K Hayward; E Gillanders; D E Elder; M F Avril; E Azizi; P van Belle; W Bergman; G Bianchi-Scarrà; B Bressac-de Paillerets; D Calista; C Carrera; J Hansson; M Harland; D Hogg; V Höiom; E A Holland; C Ingvar; M T Landi; J M Lang; R M Mackie; G J Mann; M E Ming; C J Njauw; H Olsson; J Palmer; L Pastorino; S Puig; J Randerson-Moor; M Stark; H Tsao; M A Tucker; P van der Velden; X R Yang; N Gruis
Journal:  J Natl Cancer Inst       Date:  2010-09-28       Impact factor: 13.506

Review 7.  G-protein-coupled receptors and melanoma.

Authors:  Hwa Jin Lee; Brian Wall; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2008-05-27       Impact factor: 4.693

8.  MC1R variants increase risk of melanomas harboring BRAF mutations.

Authors:  Maria Concetta Fargnoli; Maria Concetia Fargnoli; Kris Pike; Ruth M Pfeiffer; Shirley Tsang; Ester Rozenblum; David J Munroe; Yelena Golubeva; Donato Calista; Stefania Seidenari; Daniela Massi; Paolo Carli; Juergen Bauer; David E Elder; Boris C Bastian; Ketty Peris; Maria T Landi
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

9.  Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.

Authors:  Valérie Chaudru; M T Lo; F Lesueur; C Marian; H Mohamdi; K Laud; M Barrois; A Chompret; M F Avril; F Demenais; B Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2009-05-31       Impact factor: 2.375

10.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.